CategoriesAnnual General Meeting Beat Cancer Plan Beating Cancer Plan Biomarkers biosimilars Cancer Mission carers Carers Portal Clinical Trials colorectal cancer COR2ED COVID-19 DiCE DiCE Masterclass Dice members DiCE Survey drugs ECCAM ESMO GI EU4Health EU Commission EU Health Policy Platform EU Policy European Cancer Organisation events Gastric cancer health tips liver cancer mCRC medical education medical news metastatic colorectal cancer oesophageal cancer pancreatic cancer Partners patient education patient stories rare cancers research screening statistics Testing Thematic Network treatment wolfram nolte memorial award
DiCE Partner COR2ED Launches E-Learning Programme on Targeted Therapy Skin Reactions
With DiCE patient input, our partner COR2ED, creator of high-quality Independent Medical Education programmes has launched a new e-learning programme for healthcare professionals working in digestive and liver cancer. This programme helps doctors and nurses to better prevent, diagnose and manage skin reactions to targeted therapy.
Patients with digestive cancers, such as colorectal cancer, pancreatic cancer, liver cancer, neuroendocrine tumours, gastric cancer and GIST, can be treated with targeted therapies. These treatments can cause skin reactions, such as rash, dry skin, itch and changes in the hair, nails or mouth. Taking precautionary measures can help prevent these reactions and increased awareness of skin reactions will help doctors and nurses diagnose and treat them earlier. This may improve general patient wellbeing and may allow patients to remain longer on therapy.
The e-learning comes with a downloadable patient leaflet on what patients can do to prevent and manage skin reactions.
The programme has been developed by a group of experts, consisting of a medical oncologist, a liver specialist, a nurse practitioner and a dermatologist. DiCE is pleased to have volunteered its services towards the project as a long-term COR2ED partner.
Visit the learning programme.